CASP2 And RIPK1 Domain Containing Adaptor With Death Domain Protein (CRADD) Antibody (HRP)

Este producto es parte de CRADD - Death domain-containing protein CRADD
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
CASP2 And RIPK1 Domain Containing Adaptor With Death Domain Protein (CRADD) Antibody (HRP)
category
Primary Antibodies
provider
Abbexa
reference
abx108168
tested applications
ELISA

Description

Death domain-containing protein CRADD Antibody (HRP) is a Rabbit Polyclonal antibody against Death domain-containing protein CRADD conjugated to HRP.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
CASP2 And RIPK1 Domain Containing Adaptor With Death Domain Protein (CRADD)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
HRP
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P78560
Gene ID
8738
NCBI Accession
NP_001307028.1, NM_001320099.1
OMIM
603454
Alias
RAIDD, MRT34,CASP2,RIPK1,CRADD
Background
Antibody anti-CRADD
Status
RUO

Descripción

Death domain-containing protein CRADD, also known as RIP, is involved in mediating cellular responses to stress, particularly in the regulation of apoptosis. It contains a death domain (DD) and serves as a key adaptor protein in the signaling pathways triggered by death receptors. CRADD is known to participate in the formation of the death-inducing signaling complex (DISC) when activated by signals such as tumor necrosis factor (TNF) or Fas ligand (FasL), leading to the activation of caspases and subsequent apoptosis. In addition, CRADD has been implicated in other processes, such as inflammation and neurodegeneration. Its expression and function are tightly regulated and have been linked to both cell survival and death in different contexts.

Related Products

FNab07092

anti- RAIDD antibody

RAIDD, also named as CRADD, is an apoptotic adaptor molecule specific for caspase-2 and FASL/TNF receptor-interacting protein RIP. In the presence of RIP and TRADD, CRADD recruits caspase-2 to the TNFR-1 signalling complex. CRADD interacts with BCL10 through its caspase recruitment domain and suppresses interactions between BCL10 and CARMA1. It is a negative regulator of the CARMA1 signalosome and suppressor of Th1-and Th17-mediated inflammatory responses.

Ver Producto
P5563

Recombinant Human CRADD

Ver Producto
abx001039

CASP2 And RIPK1 Domain Containing Adaptor With Death Domain (CRADD) Antibody

CRADD Antibody is a Rabbit Polyclonal antibody against CRADD. The protein encoded by this gene is a death domain (CARD/DD)-containing protein and has been shown to induce cell apoptosis. Through its CARD domain, this protein interacts with, and thus recruits, caspase 2/ICH1 to the cell death signal transduction complex that includes tumor necrosis factor receptor 1 (TNFR1A), RIPK1/RIP kinase, and numbers of other CARD domain-containing proteins. [provided by RefSeq, Jul 2008].

Ver Producto